Melvin Gonzaga, MD, who owns and operates Gonzaga Interventional Pain Management, and his son, Rommel Gonzanga, the CEO, were accused of billing Medicare, Medicaid and Railroad Retirement Board for a large number of the tests.
The tests were allegedly ordered Jan. 1, 2016, through March 31, 2019.
